Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Globalizing the Scientific Bandwagon: Trajectories of Precision Medicine in China and Brazil

Full text
Author(s):
Au, Larry [1] ; da Silva, Renan Goncalves Leonel [2]
Total Authors: 2
Affiliation:
[1] Columbia Univ, Dept Sociol, 606 W 122nd St, New York, NY 10027 - USA
[2] Univ Sao Paulo, Fac Med, Sci & Technol Studies, Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: SCIENCE TECHNOLOGY & HUMAN VALUES; v. 46, n. 1 JUN 2020.
Web of Science Citations: 1
Abstract

Precision medicine (PM) is emerging as a scientific bandwagon within the contemporary biomedical sciences in the United States. PM brings together concepts and tools from genomics and bioinformatics to develop better diagnostics and therapies based on individualized information. Developing countries like China and Brazil have also begun pursuing PM projects, motivated by a desire to claim genomic sovereignty over its population. In spite of commonalities, institutional arrangements produced by the history of genomics research in China and Brazil are ushering PM along different trajectories. In the Chinese case, we identify a strong state-backed push for PM combined with a dynamic network of international academic and private actors along the lines of networked technonationalism that has made large-scale, speculative PM projects possible. The Brazilian case is characterized by an institutional void at the federal level in which PM is driven by domestic academic actors in universities in the regional level, resulting in smaller scale, needs-driven PM projects. Through these cases, this paper shows how a scientific bandwagon adapts to national histories and institutions. Through this peripheral translation of the scientific bandwagon, the global infrastructure of biomedical knowledge has the potential to be transformed. (AU)

FAPESP's process: 17/18500-0 - The innovation dynamics of the biopharmaceutical industry: new theories about technological change in monoclonal antibodies development
Grantee:Renan Gonçalves Leonel da Silva
Support Opportunities: Scholarships abroad - Research Internship - Post-doctor
FAPESP's process: 15/24133-5 - The Science, Technology and Innovation Policy for health in Brazil: the role of institutional and political framework in the development of research on Monoclonal Antibodies
Grantee:Renan Gonçalves Leonel da Silva
Support Opportunities: Scholarships in Brazil - Post-Doctoral